78 related articles for article (PubMed ID: 15519752)
1. Labeling of the scrapie-associated prion protein in vitro and in vivo.
Hoefert VB; Aiken JM; McKenzie D; Johnson CJ
Neurosci Lett; 2004 Nov; 371(2-3):176-80. PubMed ID: 15519752
[TBL] [Abstract][Full Text] [Related]
2. Proteinase K-sensitive disease-associated ovine prion protein revealed by conformation-dependent immunoassay.
Thackray AM; Hopkins L; Bujdoso R
Biochem J; 2007 Jan; 401(2):475-83. PubMed ID: 17018021
[TBL] [Abstract][Full Text] [Related]
3. A special report I. Prion protein (Prp)--amyloid plaques in the transmissible spongiform encephalopathies (TSEs) or prion disease revisited.
Liberski PP; Bratosiewicz J; Waliś A; Kordek R; Jeffrey M; Brown P
Pol J Pathol; 2001; 52(4):169-86. PubMed ID: 11915178
[TBL] [Abstract][Full Text] [Related]
4. [Novel tool for diagnosis of amyloidosis].
Obayashi K; Ando Y
Rinsho Byori; 2008 Nov; 56(11):986-93. PubMed ID: 19086454
[TBL] [Abstract][Full Text] [Related]
5. A rapid dual staining procedure for the quantitative discrimination of prion amyloid from tissues reveals how interactions between amyloid and lipids in tissue homogenates may hinder the detection of prions.
Hervé R; Collin R; Pinchin HE; Secker T; Keevil CW
J Microbiol Methods; 2009 Apr; 77(1):90-7. PubMed ID: 19318058
[TBL] [Abstract][Full Text] [Related]
6. Detection of prion particles in samples of BSE and scrapie by fluorescence correlation spectroscopy without proteinase K digestion.
Birkmann E; Schäfer O; Weinmann N; Dumpitak C; Beekes M; Jackman R; Thorne L; Riesner D
Biol Chem; 2006 Jan; 387(1):95-102. PubMed ID: 16497169
[TBL] [Abstract][Full Text] [Related]
7. Redox metals and oxidative abnormalities in human prion diseases.
Petersen RB; Siedlak SL; Lee HG; Kim YS; Nunomura A; Tagliavini F; Ghetti B; Cras P; Moreira PI; Castellani RJ; Guentchev M; Budka H; Ironside JW; Gambetti P; Smith MA; Perry G
Acta Neuropathol; 2005 Sep; 110(3):232-8. PubMed ID: 16096758
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
[TBL] [Abstract][Full Text] [Related]
9. Preparation of soluble infectious samples from scrapie-infected brain: a new tool to study the clearance of transmissible spongiform encephalopathy agents during plasma fractionation.
Berardi VA; Cardone F; Valanzano A; Lu M; Pocchiari M
Transfusion; 2006 Apr; 46(4):652-8. PubMed ID: 16584444
[TBL] [Abstract][Full Text] [Related]
10. A novel copper-hydrogen peroxide formulation for prion decontamination.
Solassol J; Pastore M; Crozet C; Perrier V; Lehmann S
J Infect Dis; 2006 Sep; 194(6):865-9. PubMed ID: 16941355
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical localization of prion protein in spongiform encephalopathies and normal brain tissue.
Piccardo P; Safar J; Ceroni M; Gajdusek DC; Gibbs CJ
Neurology; 1990 Mar; 40(3 Pt 1):518-22. PubMed ID: 1690364
[TBL] [Abstract][Full Text] [Related]
12. Elevated manganese levels in blood and central nervous system occur before onset of clinical signs in scrapie and bovine spongiform encephalopathy.
Hesketh S; Sassoon J; Knight R; Hopkins J; Brown DR
J Anim Sci; 2007 Jun; 85(6):1596-609. PubMed ID: 17296770
[TBL] [Abstract][Full Text] [Related]
13. ST1859 reduces prion infectivity and increase survival in experimental scrapie.
Colombo L; Piovesan P; Ghirardi O; Salmona M; Forloni G
Arch Virol; 2009; 154(9):1539-44. PubMed ID: 19685199
[TBL] [Abstract][Full Text] [Related]
14. Anchorless prion protein results in infectious amyloid disease without clinical scrapie.
Chesebro B; Trifilo M; Race R; Meade-White K; Teng C; LaCasse R; Raymond L; Favara C; Baron G; Priola S; Caughey B; Masliah E; Oldstone M
Science; 2005 Jun; 308(5727):1435-9. PubMed ID: 15933194
[TBL] [Abstract][Full Text] [Related]
15. Amyloid imaging probes are useful for detection of prion plaques and treatment of transmissible spongiform encephalopathies.
Ishikawa K; Doh-Ura K; Kudo Y; Nishida N; Murakami-Kubo I; Ando Y; Sawada T; Iwaki T
J Gen Virol; 2004 Jun; 85(Pt 6):1785-1790. PubMed ID: 15166464
[TBL] [Abstract][Full Text] [Related]
16. Adenosine A1 receptor protein levels and activity is increased in the cerebral cortex in Creutzfeldt-Jakob disease and in bovine spongiform encephalopathy-infected bovine-PrP mice.
Rodríguez A; Martín M; Albasanz JL; Barrachina M; Espinosa JC; Torres JM; Ferrer I
J Neuropathol Exp Neurol; 2006 Oct; 65(10):964-75. PubMed ID: 17021401
[TBL] [Abstract][Full Text] [Related]
17. KDEL-tagged anti-prion intrabodies impair PrP lysosomal degradation and inhibit scrapie infectivity.
Vetrugno V; Cardinale A; Filesi I; Mattei S; Sy MS; Pocchiari M; Biocca S
Biochem Biophys Res Commun; 2005 Dec; 338(4):1791-7. PubMed ID: 16288721
[TBL] [Abstract][Full Text] [Related]
18. Cerebral amyloid angiopathy with co-localization of prion protein and beta-amyloid in an 85-year-old patient with sporadic Creutzfeldt-Jakob disease.
Paquet C; Privat N; Kaci R; Polivka M; Dupont O; Haïk S; Laplanche JL; Hauw JJ; Gray F
Acta Neuropathol; 2008 Nov; 116(5):567-73. PubMed ID: 18551298
[TBL] [Abstract][Full Text] [Related]
19. Different prion conformers target the olfactory pathway in sporadic Creutzfeldt-Jakob disease.
Zanusso G; Ferrari S; Benedetti D; Sbriccoli M; Rizzuto N; Monaco S
Ann N Y Acad Sci; 2009 Jul; 1170():637-43. PubMed ID: 19686205
[TBL] [Abstract][Full Text] [Related]
20. The use of non-prion biomarkers for the diagnosis of Transmissible Spongiform Encephalopathies in the live animal.
Parveen I; Moorby J; Allison G; Jackman R
Vet Res; 2005; 36(5-6):665-83. PubMed ID: 16120244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
